Apabetalone Falls Short in Patients with T2D and ACS
MedPage Today,
PHILADELPHIA -- Investigational apabetalone was not better than placebo on a background of optimal medical therapy for reducing…
PHILADELPHIA -- Investigational apabetalone was not better than placebo on a background of optimal medical therapy for reducing…
Resverlogix is to release topline Phase 3 results from the BETonMACE phase 3 clinical trial on September 30.